Cargando…

FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma

Fibrinogen C domain-containing 1 (FIBCD1) is an acetyl-recognition receptor that affects the occurrence and development of certain tumors. However, the prognostic significance of FIBCD1 in hepatocellular carcinoma (HCC) remains unclear. This study aimed to explore FIBCD1 expression in HCC and to det...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Sun, Mengjing, Liu, Jibin, Liu, Ying, Jiang, Chunyi, Zhu, Huijun, Wang, Wei, Wang, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924150/
https://www.ncbi.nlm.nih.gov/pubmed/31897196
http://dx.doi.org/10.3892/ol.2019.11183
_version_ 1783481674047160320
author Wang, Yan
Sun, Mengjing
Liu, Jibin
Liu, Ying
Jiang, Chunyi
Zhu, Huijun
Wang, Wei
Wang, Yao
author_facet Wang, Yan
Sun, Mengjing
Liu, Jibin
Liu, Ying
Jiang, Chunyi
Zhu, Huijun
Wang, Wei
Wang, Yao
author_sort Wang, Yan
collection PubMed
description Fibrinogen C domain-containing 1 (FIBCD1) is an acetyl-recognition receptor that affects the occurrence and development of certain tumors. However, the prognostic significance of FIBCD1 in hepatocellular carcinoma (HCC) remains unclear. This study aimed to explore FIBCD1 expression in HCC and to determine the prognostic value of FIBCD1 in patients with HCC. A total of 1,058 liver tissue samples with detailed and complete clinical information were collected, including 495 HCC samples. Tissue microarray immunohistochemistry analysis was used to evaluate FIBCD1 protein expression in the collected tissues. The Kaplan-Meier plotter online tool was used to investigate the association between FIBCD1 expression and prognosis of patients with HCC. Oncomine and the Gene Expression Profiling Interactive Analysis database were used for bioinformatics analysis of FIBCD1. Results showed that FIBCD1 expression was higher in HCC and was associated with tumor diameter (P=0.002), tumor number (P=0.001), tumor node metastasis stage (P<0.001), primary tumor (T; P<0.001), lymph node metastases (N; P=0.002), distant metastases (M; P=0.023), differentiation degree (P=0.003), vascular invasion (P<0.001) and liver cirrhosis (P=0.011). Patients with HCC and high FIBCD1 expression had worse overall survival than those with low FIBCD1 expression. High FIBCD1 expression (P<0.001), TNM stage (P=0.003), T (P<0.001), N (P=0.014), and vascular invasion (P<0.001) were independent prognostic factors in HCC. Hence, FIBCD1 may be a novel biomarker for prognosis evaluation of HCC.
format Online
Article
Text
id pubmed-6924150
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-69241502020-01-02 FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma Wang, Yan Sun, Mengjing Liu, Jibin Liu, Ying Jiang, Chunyi Zhu, Huijun Wang, Wei Wang, Yao Oncol Lett Articles Fibrinogen C domain-containing 1 (FIBCD1) is an acetyl-recognition receptor that affects the occurrence and development of certain tumors. However, the prognostic significance of FIBCD1 in hepatocellular carcinoma (HCC) remains unclear. This study aimed to explore FIBCD1 expression in HCC and to determine the prognostic value of FIBCD1 in patients with HCC. A total of 1,058 liver tissue samples with detailed and complete clinical information were collected, including 495 HCC samples. Tissue microarray immunohistochemistry analysis was used to evaluate FIBCD1 protein expression in the collected tissues. The Kaplan-Meier plotter online tool was used to investigate the association between FIBCD1 expression and prognosis of patients with HCC. Oncomine and the Gene Expression Profiling Interactive Analysis database were used for bioinformatics analysis of FIBCD1. Results showed that FIBCD1 expression was higher in HCC and was associated with tumor diameter (P=0.002), tumor number (P=0.001), tumor node metastasis stage (P<0.001), primary tumor (T; P<0.001), lymph node metastases (N; P=0.002), distant metastases (M; P=0.023), differentiation degree (P=0.003), vascular invasion (P<0.001) and liver cirrhosis (P=0.011). Patients with HCC and high FIBCD1 expression had worse overall survival than those with low FIBCD1 expression. High FIBCD1 expression (P<0.001), TNM stage (P=0.003), T (P<0.001), N (P=0.014), and vascular invasion (P<0.001) were independent prognostic factors in HCC. Hence, FIBCD1 may be a novel biomarker for prognosis evaluation of HCC. D.A. Spandidos 2020-01 2019-12-04 /pmc/articles/PMC6924150/ /pubmed/31897196 http://dx.doi.org/10.3892/ol.2019.11183 Text en Copyright: © Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Wang, Yan
Sun, Mengjing
Liu, Jibin
Liu, Ying
Jiang, Chunyi
Zhu, Huijun
Wang, Wei
Wang, Yao
FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
title FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
title_full FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
title_fullStr FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
title_full_unstemmed FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
title_short FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
title_sort fibcd1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924150/
https://www.ncbi.nlm.nih.gov/pubmed/31897196
http://dx.doi.org/10.3892/ol.2019.11183
work_keys_str_mv AT wangyan fibcd1overexpressionpredictspoorprognosisinpatientswithhepatocellularcarcinoma
AT sunmengjing fibcd1overexpressionpredictspoorprognosisinpatientswithhepatocellularcarcinoma
AT liujibin fibcd1overexpressionpredictspoorprognosisinpatientswithhepatocellularcarcinoma
AT liuying fibcd1overexpressionpredictspoorprognosisinpatientswithhepatocellularcarcinoma
AT jiangchunyi fibcd1overexpressionpredictspoorprognosisinpatientswithhepatocellularcarcinoma
AT zhuhuijun fibcd1overexpressionpredictspoorprognosisinpatientswithhepatocellularcarcinoma
AT wangwei fibcd1overexpressionpredictspoorprognosisinpatientswithhepatocellularcarcinoma
AT wangyao fibcd1overexpressionpredictspoorprognosisinpatientswithhepatocellularcarcinoma